mk2 Biotechnologies develops, produces and investigates peptides and proteins using a synthesis technology, enabling their cost-efficient production for various applications.

mk2 Biotechnologies

mk2 Biotechnologies | 1,216 followers on LinkedIn. Peptides &amp; Proteins for Mass Applications | mk2 Biotechnologies develops, produces and investigates peptides &amp; proteins using a revolutionary synthesis technology. Our innovative process allows the scalable and thus cost-efficient production of high-purity peptides &amp; proteins for a broad range of applications.

CEO at mohemian

Florian Scholochow

think bigger and never give up!!

René Schmidt

Head of Business Development | Biochemistry, Biophysics, Strategic Business Development

Priya Gurumoorthy, Ph.D.

Senior Advisor / Organisationsentwickler/ Projektcoach/ Founding & Business Angel

Thomas Leitgeb

The Finance Days at the analytica were a great opportunity for our CEO Konstantinos Antonopoulos to have a chat with a lot of fantastic people from the broader space and to develop creative solutions on the spot. If you're still around Munich and want to meet up, let us know! #proteins #peptides Christian Gnam IZB - Innovation and Start-up Center Biotechnology

Don't miss the opportunity to meet Priya Gurumoorthy, Ph.D. at the Meat Evolution Leaders Summit in Barcelona on Feb 7th/8th to check out our newest developments on growth factors and many more bioactive proteins.

MK2

BIO:MK2

mk2 Biotechnologies

locale

market

industry

website

crunchbase

linkedin

peer of

Metrics